Studies have demonstrated that either genetic deletion or pharmacological inhibition of TLR4 can effectively prevent bladder inflammation in mouse models of cyclophosphamide (CYP)-induced cystitis [15, 16]. Here, TLR4 is linked to chronic cystitis.